跳至主要内容
临床试验/CTRI/2023/07/055320
CTRI/2023/07/055320尚未招募2 期

Evaluation of the safety and efficacy of Qurs Tinkar for the management of dyslipidemia - A randomized controlled trial

uqman Unani Medical college hospital and research centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants of any gender.
  • -Age between 20 and 60 years.
  • -Participants with serum cholesterol more than or equal to 200mg per dL, serum triglycerides(TG) more than or equal to 150mg per dL, Low Density Lipoprotein cholesterol (LDL) more than or equal to 130mg per dL, High Density Lipoprotein (HDL) less than or equal to 40 mg per dL.

排除标准

  • -Participants with comorbidities such as IHD, hypertension, diabetes, chronic kidney disease, malignancy, and other aggravating conditions.
  • -Pregnant & lactating women

研究者

发起方
uqman Unani Medical college hospital and research centre

相似试验